Casalini P - Search Results

1

Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress.

Triulzi T, Casalini P, Sandri M, Ratti M, Carcangiu ML, Colombo MP, Balsari A, Ménard S, Orlandi R, Tagliabue E. Triulzi T, et al. Among authors: casalini p. PLoS One. 2013;8(2):e56761. doi: 10.1371/journal.pone.0056761. Epub 2013 Feb 18. PLoS One. 2013. PMID: 23441215 Free PMC article.

2

FOXP3 expression and overall survival in breast cancer.

Merlo A, Casalini P, Carcangiu ML, Malventano C, Triulzi T, Mènard S, Tagliabue E, Balsari A. Merlo A, et al. Among authors: casalini p. J Clin Oncol. 2009 Apr 10;27(11):1746-52. doi: 10.1200/JCO.2008.17.9036. Epub 2009 Mar 2. J Clin Oncol. 2009. PMID: 19255331

3

FOXP3 expression in tumor cells and implications for cancer progression.

Triulzi T, Tagliabue E, Balsari A, Casalini P. Triulzi T, et al. Among authors: casalini p. J Cell Physiol. 2013 Jan;228(1):30-5. doi: 10.1002/jcp.24125. J Cell Physiol. 2013. PMID: 22674548 Review.

4

Maspin influences response to doxorubicin by changing the tumor microenvironment organization.

Triulzi T, Ratti M, Tortoreto M, Ghirelli C, Aiello P, Regondi V, Di Modica M, Cominetti D, Carcangiu ML, Moliterni A, Balsari A, Casalini P, Tagliabue E. Triulzi T, et al. Among authors: casalini p. Int J Cancer. 2014 Jun 15;134(12):2789-97. doi: 10.1002/ijc.28608. Epub 2013 Nov 30. Int J Cancer. 2014. PMID: 24242003

5

SEL1L expression decreases breast tumor cell aggressiveness in vivo and in vitro.

Orlandi R, Cattaneo M, Troglio F, Casalini P, Ronchini C, Ménard S, Biunno I. Orlandi R, et al. Among authors: casalini p. Cancer Res. 2002 Jan 15;62(2):567-74. Cancer Res. 2002. PMID: 11809711

6

HER-2-positive breast carcinomas as a particular subset with peculiar clinical behaviors.

Ménard S, Balsari A, Casalini P, Tagliabue E, Campiglio M, Bufalino R, Cascinelli N. Ménard S, et al. Among authors: casalini p. Clin Cancer Res. 2002 Feb;8(2):520-5. Clin Cancer Res. 2002. PMID: 11839672

7

HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancer.

Moliterni A, Ménard S, Valagussa P, Biganzoli E, Boracchi P, Balsari A, Casalini P, Tomasic G, Marubini E, Pilotti S, Bonadonna G. Moliterni A, et al. Among authors: casalini p. J Clin Oncol. 2003 Feb 1;21(3):458-62. doi: 10.1200/JCO.2003.04.021. J Clin Oncol. 2003. PMID: 12560435 Clinical Trial.

8

Linking survival of HER2-positive breast carcinoma patients with surgical invasiveness.

Tagliabue E, Agresti R, Casalini P, Mariani L, Carcangiu ML, Balsari A, Veronesi U, Ménard S. Tagliabue E, et al. Among authors: casalini p. Eur J Cancer. 2006 May;42(8):1057-61. doi: 10.1016/j.ejca.2005.12.021. Epub 2006 Apr 18. Eur J Cancer. 2006. PMID: 16624551 Clinical Trial.

9

Relationship between p53 and p27 expression following HER2 signaling.

Casalini P, Iorio MV, Berno V, Bergamaschi A, Børresen Dale AL, Gasparini P, Orlandi R, Casati B, Tagliabue E, Ménard S. Casalini P, et al. Breast. 2007 Dec;16(6):597-605. doi: 10.1016/j.breast.2007.05.007. Epub 2007 Jun 28. Breast. 2007. PMID: 17604627 Free article.

10

Two distinct local relapse subtypes in invasive breast cancer: effect on their prognostic impact.

Casalini P, Carcangiu ML, Tammi R, Auvinen P, Kosma VM, Valagussa P, Greco M, Balsari A, Ménard S, Tagliabue E. Casalini P, et al. Clin Cancer Res. 2008 Jan 1;14(1):25-31. doi: 10.1158/1078-0432.CCR-07-0450. Clin Cancer Res. 2008. PMID: 18172248

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters